AAAAAA

   
Results: 1-25 | 26-50 | 51-70
Results: 1-25/70
PREOPERATIVE CHEMOTHERAPY AND RADIOTHERAPY IN BREAST-CANCER
Authors: COLLEONI M NOLE F MINCHELLA I NOBERASCO C LUINI A ORECCHIA A VERONESI P ZURRIDA S VIALE G GOLDHIRSCH A
Citation: M. Colleoni et al., PREOPERATIVE CHEMOTHERAPY AND RADIOTHERAPY IN BREAST-CANCER, European journal of cancer, 34(5), 1998, pp. 641-645
PREDICTION OF RESPONSE TO PRIMARY CHEMOTHERAPY (PCT) FOR OPERABLE BREAST-CANCER
Authors: COLLEONI M MINCHELLA I ORVIETO E PERUZZOTTI G NOLE F VIALE G NOBERASCO C SACCHINI V VERONESI P ORECCHIA R GOLDHIRSCH A
Citation: M. Colleoni et al., PREDICTION OF RESPONSE TO PRIMARY CHEMOTHERAPY (PCT) FOR OPERABLE BREAST-CANCER, European journal of cancer, 34, 1998, pp. 12-12
CONTINUOUS-INFUSION OF 5-FLUOROURACIL (CIFU) GIVEN WITH VINORELBINE (VI) AND CISPLATIN (P) (VIFUP) IN HEAVILY PRETREATED METASTATIC BREAST-CANCER
Authors: NOLE F MUNZONE E ZAMPINO MG MINCHELLA I COLLEONI M NOBERASCO C DEPAS T FAZIO N DEBRAUD F PERUZZOTTI G GOLDHIRSCH A
Citation: F. Nole et al., CONTINUOUS-INFUSION OF 5-FLUOROURACIL (CIFU) GIVEN WITH VINORELBINE (VI) AND CISPLATIN (P) (VIFUP) IN HEAVILY PRETREATED METASTATIC BREAST-CANCER, European journal of cancer, 34, 1998, pp. 33-33
DOSE-RESPONSE EFFECT OF ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL (CMF) IN NODE-POSITIVE BREAST-CANCER
Authors: COLLEONI M PRICE K CASTIGLIONEGERTSCH M GOLDHIRSCH A COATES A LINDTNER J COLLINS J GELBER RD THURLIMANN B RUDENSTAM CM
Citation: M. Colleoni et al., DOSE-RESPONSE EFFECT OF ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL (CMF) IN NODE-POSITIVE BREAST-CANCER, European journal of cancer, 34(11), 1998, pp. 1693-1700
ESOPHAGEAL CANCER-TREATMENT - STUDIES, STRATEGIES AND FACTS
Authors: WOBST A AUDISIO RA COLLEONI M GERAGHTY JG
Citation: A. Wobst et al., ESOPHAGEAL CANCER-TREATMENT - STUDIES, STRATEGIES AND FACTS, Annals of oncology, 9(9), 1998, pp. 951-962
ADDING ADJUVANT CMF CHEMOTHERAPY TO EITHER RADIOTHERAPY OR TAMOXIFEN - ARE ALL CMFS ALIKE
Authors: GOLDHIRSCH A COLLEONI M COATES AS CASTIGLIONEGERTSCH M GELBER RD
Citation: A. Goldhirsch et al., ADDING ADJUVANT CMF CHEMOTHERAPY TO EITHER RADIOTHERAPY OR TAMOXIFEN - ARE ALL CMFS ALIKE, Annals of oncology, 9(5), 1998, pp. 489-493
FACTORS PREDICTIVE OF RESPONSE TO PRIMARY CHEMOTHERAPY FOR OPERABLE BREAST-CANCER
Authors: COLLEONI M ORVIETO E NOLE F ORLANDO L VIALE G PERUZZOTTI G SACCHINI V VERONESI P ORECCHIA R GOLDHIRSCH A
Citation: M. Colleoni et al., FACTORS PREDICTIVE OF RESPONSE TO PRIMARY CHEMOTHERAPY FOR OPERABLE BREAST-CANCER, Annals of oncology, 9, 1998, pp. 29-29
HEPATIC TOXICITY DURING ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE AND 5-FLUOROURACIL (CMF) IN BREAST-CANCER
Authors: NOBERASCO C PERUZZOTTI G COLLEONI M NOLE F DEBRAUD F MARTINELLI G GOLDHIRSCH A
Citation: C. Noberasco et al., HEPATIC TOXICITY DURING ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE AND 5-FLUOROURACIL (CMF) IN BREAST-CANCER, Annals of oncology, 9, 1998, pp. 30-30
PRIMARY CHEMOTHERAPY IN OPERABLE BREAST-CANCER (OBC) USING A REGIMEN WITH A LOW SUBJECTIVE TOXIC BURDEN CONTAINING VINORELBINE (V), 5-FLUOROURACIL (FU) AND FOLINIC ACID (FA)
Authors: NOLE F COLLEONI M DEBRAUD F ZAMPINO MG MINCHELLA I ORLANDO L VERONESI P SACCHINI V GOLDHIRSCH A
Citation: F. Nole et al., PRIMARY CHEMOTHERAPY IN OPERABLE BREAST-CANCER (OBC) USING A REGIMEN WITH A LOW SUBJECTIVE TOXIC BURDEN CONTAINING VINORELBINE (V), 5-FLUOROURACIL (FU) AND FOLINIC ACID (FA), Annals of oncology, 9, 1998, pp. 39-39
HEPATIC INTRAARTERIAL CHEMOTHERAPY (HIAC) WITH FLUOROURACIL, CISPLATIN AND MITOMYCIN-C IN PRIMARY AND SECONDARY LIVER-TUMORS VIA PERCUTANEOUS CATHETER - A FEASIBILITY STUDY
Authors: FAZIO N DEBRAUD F COLLEONI M ORSI F GRASSO F MARENGHI C DEPAS T GASPARETTO M NOLE F GOLDHIRSCH A
Citation: N. Fazio et al., HEPATIC INTRAARTERIAL CHEMOTHERAPY (HIAC) WITH FLUOROURACIL, CISPLATIN AND MITOMYCIN-C IN PRIMARY AND SECONDARY LIVER-TUMORS VIA PERCUTANEOUS CATHETER - A FEASIBILITY STUDY, Annals of oncology, 9, 1998, pp. 254-254
ASSESSMENT OF RESPONSE IN PRIMARY CHEMOTHERAPY FOR BREAST-CANCER
Authors: COLLEONI M ORLANDO L ROBERTSON C NOLE F PERUZZOTTI G CASSANO R ORVIETO E VIALE G GOLDHIRSCH A
Citation: M. Colleoni et al., ASSESSMENT OF RESPONSE IN PRIMARY CHEMOTHERAPY FOR BREAST-CANCER, Annals of oncology, 9(10), 1998, pp. 1140-1141
INTRACAVITARY CHEMOTHERAPY WITH THIOTEPA IN MALIGNANT PERICARDIAL-EFFUSIONS - AN ACTIVE AND WELL-TOLERATED REGIMEN
Authors: COLLEONI M MARTINELLI G BERETTA F MARONE C GALLINO A FONTANA M GRAFFEO R ZAMPINO G DEPAS T CIPOLLA G MARTINONI C GOLDHIRSCH A
Citation: M. Colleoni et al., INTRACAVITARY CHEMOTHERAPY WITH THIOTEPA IN MALIGNANT PERICARDIAL-EFFUSIONS - AN ACTIVE AND WELL-TOLERATED REGIMEN, Journal of clinical oncology, 16(7), 1998, pp. 2371-2376
ADJUVANT CHEMOENDOCRINE THERAPY IN POSTMENOPAUSAL BREAST-CANCER - CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL DOSE AND SCHEDULE MAY MAKE A DIFFERENCE
Authors: GOLDHIRSCH A COATES AS COLLEONI M CASTIGLIONEGERTSCH M GELBER RD
Citation: A. Goldhirsch et al., ADJUVANT CHEMOENDOCRINE THERAPY IN POSTMENOPAUSAL BREAST-CANCER - CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL DOSE AND SCHEDULE MAY MAKE A DIFFERENCE, Journal of clinical oncology, 16(4), 1998, pp. 1358-1362
COMBINED CHEMOENDOCRINE ADJUVANT THERAPY FOR PATIENTS WITH OPERABLE BREAST-CANCER - STILL A QUESTION
Authors: COLLEONI M COATES A PAGANI O GOLDHIRSCH A
Citation: M. Colleoni et al., COMBINED CHEMOENDOCRINE ADJUVANT THERAPY FOR PATIENTS WITH OPERABLE BREAST-CANCER - STILL A QUESTION, Cancer treatment reviews, 24(1), 1998, pp. 15-26
RADIOTHERAPY AND CHEMOTHERAPY IN HIGH-RISK BREAST-CANCER
Authors: GOLDHIRSCH A COATES AS COLLEONI M GELBER RD
Citation: A. Goldhirsch et al., RADIOTHERAPY AND CHEMOTHERAPY IN HIGH-RISK BREAST-CANCER, The New England journal of medicine, 338(5), 1998, pp. 330-331
PRACTICAL CONSIDERATIONS IN THE TREATMENT OF HEPATOCELLULAR-CARCINOMA
Authors: COLLEONI M AUDISIO RA DEBRAUD F FAZIO N MARTINELLI G GOLDHIRSCH A
Citation: M. Colleoni et al., PRACTICAL CONSIDERATIONS IN THE TREATMENT OF HEPATOCELLULAR-CARCINOMA, Drugs, 55(3), 1998, pp. 367-382
CISPLATIN, ETOPOSIDE AND BLEOMYCIN INFUSION (PEBI REGIMEN) IN GOOD-RISK PATIENTS WITH GERM-CELL TUMORS
Authors: COLLEONI M GRAFFEO R MARTINELLI G GHIELMINI M DEBRAUD P ZAMPINO G MARINI G CAVALLI F GOLDHIRSCH A
Citation: M. Colleoni et al., CISPLATIN, ETOPOSIDE AND BLEOMYCIN INFUSION (PEBI REGIMEN) IN GOOD-RISK PATIENTS WITH GERM-CELL TUMORS, Oncology Reports, 4(5), 1997, pp. 913-916
PROGNOSTIC FACTORS IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA SUBMITTED TO CHEMOEMBOLIZATION
Authors: COLLEONI M LIESSI G MASTRAPASQUA G BONI L NELLI P VICARIO G SGARBOSSA G PANCHERI F MANENTE P
Citation: M. Colleoni et al., PROGNOSTIC FACTORS IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA SUBMITTED TO CHEMOEMBOLIZATION, Oncology Reports, 4(5), 1997, pp. 1025-1028
A RANDOMIZED PHASE-II TRIAL OF CISPLATINUM PLUS MITOMYCIN-C PLUS VINORELBINE AND CARBOPLATIN PLUS VINORELBINE IN ADVANCED NONSMALL CELL LUNG-CANCER
Authors: COLLEONI M VICARIO G PANCHERI F SGARBOSSA G NELLI P MANENTE P
Citation: M. Colleoni et al., A RANDOMIZED PHASE-II TRIAL OF CISPLATINUM PLUS MITOMYCIN-C PLUS VINORELBINE AND CARBOPLATIN PLUS VINORELBINE IN ADVANCED NONSMALL CELL LUNG-CANCER, International journal of oncology, 10(3), 1997, pp. 619-622
CISPLATIN, ETOPOSIDE AND BLEOMYCIN INFUSION (PEBI REGIMEN) IN GOOD-RISK PATIENTS WITH GERM-CELL TUMORS
Authors: COLLEONI M GRAFFEO R MARTINELLI G GHIELMINI M MARINI G CAVALLI F GOLDHIRSCH A
Citation: M. Colleoni et al., CISPLATIN, ETOPOSIDE AND BLEOMYCIN INFUSION (PEBI REGIMEN) IN GOOD-RISK PATIENTS WITH GERM-CELL TUMORS, European journal of cancer, 33, 1997, pp. 176-176
FEASIBILITY OF PACLITAXEL IN A PATIENT WITH ANTHRACYCLINE-INDUCED CONGESTIVE-HEART-FAILURE
Authors: COLLEONI M NELLI P VICARIO G SGARBOSSA G PANCHERI F MANENTE P
Citation: M. Colleoni et al., FEASIBILITY OF PACLITAXEL IN A PATIENT WITH ANTHRACYCLINE-INDUCED CONGESTIVE-HEART-FAILURE, European journal of cancer, 33(2), 1997, pp. 321-322
INTRAARTERIAL CHEMOTHERAPY FOLLOWED BY CHEMOEMBOLIZATION IN UNRESECTABLE HEPATOCELLULAR-CARCINOMA
Authors: COLLEONI M LIESSI G MASTRAPASQUA G NELLI P VICARIO G SGARBOSSA G PANCHERI F MANENTE P
Citation: M. Colleoni et al., INTRAARTERIAL CHEMOTHERAPY FOLLOWED BY CHEMOEMBOLIZATION IN UNRESECTABLE HEPATOCELLULAR-CARCINOMA, European journal of cancer, 33(1), 1997, pp. 56-60
MITOMYCIN-C AND VINORELBINE IN PRETREATED BREAST-CANCER
Authors: COLLEONI M MANENTE P STOCKER J AMOR H LAMON S NELLI P VICARIO G SGARBOSSA G GRAIFF C
Citation: M. Colleoni et al., MITOMYCIN-C AND VINORELBINE IN PRETREATED BREAST-CANCER, Tumori, 83(5), 1997, pp. 834-836
INTERMITTENT CONTINUOUS-INFUSION OF FLUOROURACIL AND LOW-DOSE ORAL LEUCOVORIN IN PRETREATED BREAST-CANCER - A PILOT-STUDY
Authors: COLLEONI M VICARIO G NELLI P SGARBOSSA G PANCHERI F MANENTE P
Citation: M. Colleoni et al., INTERMITTENT CONTINUOUS-INFUSION OF FLUOROURACIL AND LOW-DOSE ORAL LEUCOVORIN IN PRETREATED BREAST-CANCER - A PILOT-STUDY, Tumori, 83(3), 1997, pp. 665-668
PHASE-II STUDY OF ESTRAMUSTINE, ORAL ETOPOSIDE, AND VINORELBINE IN HORMONE-REFRACTORY PROSTATE-CANCER
Authors: COLLEONI M GRAIFF C VICARIO G NELLI P SGARBOSSA G PANCHERI F MANENTE P
Citation: M. Colleoni et al., PHASE-II STUDY OF ESTRAMUSTINE, ORAL ETOPOSIDE, AND VINORELBINE IN HORMONE-REFRACTORY PROSTATE-CANCER, American journal of clinical oncology, 20(4), 1997, pp. 383-386
Risultati: 1-25 | 26-50 | 51-70